tirzepatide similar drugs Mounjaro, Zepbound: Generic GLP-1 May Soon Be Available Tirzepatide outperformed semaglutide weight-loss drug

The SURMOUNT-1 trial (Jastreboff et al., New England Journal of Medicine 2022) enrolled 2,539 adults with obesity and demonstrated 15% to 20.9% total body weight loss over 72 weeks

A newer FDA cleared, prescription only device Epitomee Medical is now part of the conversation in obesity care

But for those willing to do the work, the results speak for themselves

Tirzepatide is a special kind of medicine that works on two receptors - glucose-dependent insulinotropic polypeptide (GIP) and GLP-1

For many individuals, GLP-1 therapy can finally make weight loss feel achievable after years of frustration with restrictive diets and short-term solutions

After reconstitution with bacteriostatic water, refrigerate at 28C and use within 8 weeks